Donald A. Vena
19 works · 2,179 citations · h-index 16
Top works
- Measuring Response in Solid Tumors: Unidimensional Versus Bidimensional Measurement
- Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.
- Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial.
- A phase III multi-institutional randomized study of immunization with the gp100: 209–217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma
- A phase III multi-institutional randomized study of immunization with the gp100: 209–217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma
- Second Malignancies as a Consequence of Nucleoside Analog Therapy for Chronic Lymphoid Leukemias
- Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
- Neurotoxicity of purine analogs: a review.
- Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.
- Preoperative and Postoperative Combination Chemotherapy for Potentially Resectable Gastric Carcinoma
- Risk Factors for Osteonecrosis of the Jaws
- Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.
- Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRN.
- Bevacizumab (BV) plus 5-FU/leucovorin (FU/LV) for advanced colorectal cancer (CRC) that progressed after standard chemotherapies: An NCI Treatment Referral Center trial (TRC-0301)
- The PBRN Initiative
- Dental risk factors for osteonecrosis of the jaws: a CONDOR case–control study
- A phase III multi-institutional randomized study of immunization with the gp100: 209–217(210M) peptide followed by high-dose IL-2 compared with high-dose IL-2 alone in patients with metastatic melanoma
- Osteonecrosis of the jaw and oral hygiene: a case-control study from Condor Dental PBRN.
- P09 Database management of national cancer institute-sponsored cancer treatment trials